Traditionally, public health agencies (PHAs) wait for hospital, laboratory or clinic staff to initiate case reports. However, this passive approach is burdensome for reporters and produces incomplete and delayed reports, which can hinder assessment of disease in the community and potentially delay recognition of patterns and outbreaks. Modern surveillance practice is shifting toward greater use of electronically transmitted disease information.

Increasingly public health decision-makers are using syndromic surveillance for real-time reassurance and situational awareness in addition to early warning1. Decision-makers using intelligence, including syndromic data, need to understand what the systems are capable of detecting, what they cannot detect and specifically how much reassurance should be inferred when syndromic systems report nothing detected. In this study we quantify the detection capabilities of syndromic surveillance systems used by Public Health England (PHE).

Hepatitis C virus (HCV) infection is a leading cause of liver disease-related morbidity and mortality in the United States. Approximately 75% of people infected with chronic HCV were born between 1945 and 1965. Since 2012, the CDC has recommended one-time screening for chronic HCV infection for all persons in this birth cohort (baby boomers). The United States Preventive Services Task Force (USPSTF) subsequently made the same recommendation in June 2013.

Infectious disease was the second most common cause of death in 1949, and the epidemic situation of infectious diseases was so severe that the Chinese government made major investments to the control and prevention of infectious diseases. During the past 60 years the development of the notifiable disease surveillance system in China has experienced 3 phases, including germination stage, development stage, improvement and consolidation stage (1).